This is the authors' abstract. We don't add key points for this paper.
Cortisol is a dynamic endocrine biomarker whose concentration varies with circadian timing, acute stressors, medication, sampling conditions and population characteristics. Saliva provides a non-invasive matrix for repeated measurement of the unbound hormone fraction and is compatible with decentralised point-of-care formats, but salivary cortisol should be interpreted as an adjunctive physiological measure rather than a standalone diagnostic test for psychiatric disorders. This review compares biological sampling matrices and critically evaluates lateral-flow immunoassays, electrochemical, surface-plasmon-resonance and quantum-dot-based cortisol sensors according to recognition chemistry, transduction mechanism, analytical range, sample matrix, validation level and translational readiness. Competitive lateral-flow assays offer rapid, low-cost and discrete measurements, whereas wearable electrochemical and microneedle platforms may support higher-frequency monitoring but face challenges in sample availability, biofouling, calibration drift and long-term stability. Across platforms, very low limits of detection do not by themselves establish suitability for salivary monitoring; physiologically relevant range coverage, authentic-saliva validation, comparison with reference methods and reproducibility are also required. Future progress will depend on standardised collection protocols, selective recognition chemistry, robust digital readout, circadian-aware interpretation and independent clinical validation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kok et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: